Adopting the Evolving Management of HR+/HER2-mBC into Practice Podcast By Annenberg Center for Health Sciences cover art

Adopting the Evolving Management of HR+/HER2-mBC into Practice

Adopting the Evolving Management of HR+/HER2-mBC into Practice

By: Annenberg Center for Health Sciences
Listen for free

Survival outcomes for patients with HR+/HER2- mBC remain suboptimal, despite first-line treatment strategies with endocrine therapy (ET). Greater understanding of the biology of HR+/HER2- mBC, including the role of biomarkers like ESR1 mutations, and the development of biopsy techniques for early mutation detection, have paved the way for personalized treatment approaches. In this activity, medical oncologists discuss integrating these evidence-based advancements into practice.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Navigating Through the Current Treatment of Patients with HR+/HER2- mBC

    Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
    Apr 9 2025

    Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
    Show more Show less
    7 mins
  • Molecular and Tumor Profiling

    Molecular and Tumor Profiling
    Apr 9 2025

    Molecular and Tumor Profiling
    Show more Show less
    23 mins
No reviews yet